Your SlideShare is downloading. ×
Tissue Engineering
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Tissue Engineering


Published on

Tissue engineering is new wing of biotechnology with great advantages.You will find its technical as well as applications in brief in this ppt.

Tissue engineering is new wing of biotechnology with great advantages.You will find its technical as well as applications in brief in this ppt.

Published in: Technology, Health & Medicine

1 Comment
  • it was so good if we could save it!
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. •Nikhil Bhalerao•RahulKumar Bhol •Girija Paranjpe •Sonali Jadhav •Pallavi Bodkhe
  • 2. Tissue Engineering Tissue engineering is TECHNOLOGY. Similar to REGENARATIVE MEDICINES. Regenerative medicines means use of STEM CELLS. STEM CELLS: 1. Embryonic stem cells 2. Adult stem cells
  • 3. Sources of cells Primary source – cells from individual(patient) Secondary source- cells from cell bank Autologous cells- cells from same person Allogenic cells-cells from same species Xenogenic cells- cells from another species Syngenic cells- cells from clones
  • 4. Scaffolds Cells are implanted or seeded into an artificial structure capable of supporting three-dimensional tissue formation. These structures typically are called as scaffolds Scaffolds usually serve at least one of the following purposes:  Allow cell attachment and migration  Deliver and retain cells and biochemical factors  Enable diffusion of vital cell nutrients and expressed products
  • 5. Requirements for scaffolds High porosity and an adequate pore size Biodegradability rate at which degradation occurs has to coincide as much as possible with the rate of tissue formation Inject ability
  • 6. Carbon Nanotube Carbon nanotubes are among the numerous types for tissue engineering scaffolds They are- biocompatible, can be functionalized with biomolecules.
  • 7. Methods for tissue engineeringscaffolds:Solvent Casting & Particulate Leaching (SCPL) It allows for the preparation of porous structures with regular porosity, but with a limited thickness Polymer- polylactic acid Solvent- dichloromethane Porogen- sodium chloride, crystals of saccharose, gelatin spheres or paraffin spheres
  • 8. Gas Foaming To overcome the need to use organic solvents and solid porogens Disc-shaped structures made Exposed to high pressure CO2 for several days Pressure inside the chamber is gradually restored to atmospheric levels Pores are formed by the carbon dioxide molecules that abandon the polymer
  • 9. Emulsification/Freeze-drying This technique does not require the use of a solid porogen A synthetic polymer is dissolved into a suitable solvent Water is added to the polymeric solution to obtain emulsion Emulsion is cast into a mold and quickly frozen Frozen emulsion is subsequently freeze-dried to remove the dispersed water and the solvent
  • 10. Thermally Induced PhaseSeparation (TIPS)
  • 11. Electro spinning
  • 12. CAD/CAM Technologies Three-dimensional structure is designed using CAD software. The porosity can be tailored using algorithms within the software
  • 13. Tissue culture Includes creation of functional tissues and biological structures in vitro It requires extensive culturing to promote survival, growth and inducement of functionality The major problem is maintaining culture conditions
  • 14. Bioreactors •Bioreactor is a device that attempts to simulate a physiological environment in order to promote cell or tissue growth in vivo
  • 15. Applications of Tissue Engineering Therapeutic cloning for tissue repair Coronary Heart Disease  Myocardial Infarction  Congestive Heart Failure  Dysfunctional Heart Valves  Peripheral Vascular Disorders  Abdominal Aortic Aneurysms
  • 16.  Neurological  Stroke  Parkinson’s Disease  Alzheimer’s Disease  Epilepsy  Traumatic Brain and Spinal Cord Injury  Multiple Sclerosis
  • 17.  Orthopedic  Non-union Fractures  Cartilage Damage and Repair  Ligament Damage  Vertebral Disc Damage  Bone Graft Materials Urological  Incontinence  Kidney Disease  Bladder
  • 18.  Dental  Missing teeth  Periodontal disease Skin/Integumentary  Burns  Diabetic Ulcers  Venous Ulcers  Plastic Surgery Ophthalmology  Cornea  Retina
  • 19.  Gastrointestinal  Esophagus  Stomach  Small Intestine  Colon Ear, Nose and Throat/Respiratory/Cardiopulmonary  Trachea  Respiratory Epithelial Cells (Nasal Turbinates) Cancer
  • 20. Organ Transplantation Bioartificial liver device: Artificial pancreas:. Artificial bladders: Cartilage: Artificial skin constructed from human skin cells embedded in collagen -Artificial bone marrow -Artificial bone -Artificial penis -Oral mucosa tissue engineering
  • 21. Some Interesting Things…
  • 22. In vitro meat
  • 23. Skin gun heals skin burns
  • 24. Bullet Proof Skin
  • 25. Living Doll
  • 26. Tissue engineered Toys
  • 27. Market scenario Treatments via cell therapy and tissue engineering constitute a $6.9 billion worldwide market. Market is predicted to grow nearly $32 billion in less than ten years. Market is growing at rate of 16%. Market demand increasing for innovative product. Over the 2009–2018 period, - organ transplantation segment is expected to grow by 46%. - dental decay and disease segment expected to grow by 21%. Increase in Indian tissue engineering market due to Medical tourism
  • 28.  Apligraf, by Organogenesis, is the first manufactured living human organ in 1997 Different product categories: − Skin substitutes − Orthopedic cartilage and bone replacement − Cardiovascular substitutes − Organs (e.g. kidney, liver, lung) − Nervous system − Soft tissue
  • 29. Tissue engineering market
  • 30. Major Market segment:  Orthopedics:  Cardiology:  Wound healing:  Diabetes:  Neurodegenerative diseases:
  • 31. Market segment andopportunitiesOrthopedics: Orthopedic segment grow at nearly 15% per year This market include spine, bone grafts, and bone substitutes. Regenerative medicine therapy is favorable. Orthopedic treatment is most popular area in Indian medical tourism. Cardiology: Regenerative medicine with applications in cardiology and vascular medicine will rank among the three fastest growing segments . As CHD (and CVD) rates increase, estimate increases to 17.9 million by 2030. In 2005, India was estimated to have 3.5 crore CHD patients while in 2010, the number stood at 4.6 crores. The most promising area for regenerative medicine is the treatment of myocardial infarction
  • 32. Wound healing Globally, 500,000 surgeries were performed to treat diabetic ulcers 500,000 surgeries to treat venous ulcers 45,000 burn surgeries 940,000 plastic surgeries are performed each year The most common application for regenerative medicine is for the treatment of burns.
  • 33. Diabetes: The number of people with diabetes globally will likely double between 2003-2030. An estimated 285 million people, corresponding to 6.4% of the worlds adult population, will live with diabetes in 2010 Surgical transplantation of pancreatic islet cells is promising applicationNeurodegenerative diseases: 18 million people worldwide with Alzheimer’s disease. 20 million people each year will suffer from stroke. 6.3 million people have Parkinson’s disease.
  • 34. Challenges: Quality control of the materials used in various surgical applications Acquiring a fundamental understanding of tissue differentiation mechanisms The industry is challenged to develop tissue- engineered products for a number of surgery- related applications, Ethical issue..
  • 35. Major market players
  • 36. Future: Technical advances in the various components of the industry will contribute to market growth. Focus on the safety and efficacy standards. Continued development of artificial organs with appropriate support structures. Focus on disease areas that have the most patients and the largest unmet needs
  • 37. Problems with Tissue engineering Complexity using Human tissue implants  Variability of cells grown.  Standardization of process  Irreversible process  Risk assessment in clinical trials & commercialization. Ethical problems
  • 38. Ethical problems•Using Xenogenic cells: Species boundaries crossed•Using Human embryonic cells: Unethical to use humanembryo & aborted fetus.•Use of human embryo with large scale cultivation for profit•Rights of Tissue Donors: -Profit making -Information
  • 39. Ethical Problems Role of Cell banks:  Privacy of Donor Prolonging of life through Tissue engineering: Set goal for raising life span through tissue engineering Playing THEE!!! Organ trafficking Cost of using Technology.
  • 40. Organizations in TE Society for Tissue Engineering and Regenerative Medicine (India) (STERMI) Society for Biomaterials & Artificial organs Society for regenerative medicines & tissue engineering (SRMTE) European tissue repair society Tissue & cell engineering society Tissue engineering & Regenerative Medicine International Society